Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers.

Fung-Leung WP, Edwards W, Liu Y, Ngo K, Angsana J, Castro G, Wu N, Liu X, Swanson RV, Wickenden AD.

PLoS One. 2017 Jan 20;12(1):e0170102. doi: 10.1371/journal.pone.0170102. eCollection 2017.

2.

The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.

Devi KS, Anandasabapathy N.

Semin Immunopathol. 2017 Feb;39(2):137-152. doi: 10.1007/s00281-016-0602-0. Epub 2016 Nov 25. Review.

PMID:
27888331
3.

Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.

Netanely D, Avraham A, Ben-Baruch A, Evron E, Shamir R.

Breast Cancer Res. 2016 Jul 7;18(1):74. doi: 10.1186/s13058-016-0724-2. Erratum in: Breast Cancer Res. 2016 Nov 28;18(1):117.

4.

Pathway analysis of expression-related SNPs on genome-wide association study of basal cell carcinoma.

Li X, Liang L, De Vivo I, Tang JY, Han J.

Oncotarget. 2016 Jun 14;7(24):36885-36895. doi: 10.18632/oncotarget.9212.

5.

Systems biology approach to studying proliferation-dependent prognostic subnetworks in breast cancer.

Song Q, Wang H, Bao J, Pullikuth AK, Li KC, Miller LD, Zhou X.

Sci Rep. 2015 Aug 10;5:12981. doi: 10.1038/srep12981.

6.

Membrane-mediated regulation of the intrinsically disordered CD3ϵ cytoplasmic tail of the TCR.

López CA, Sethi A, Goldstein B, Wilson BS, Gnanakaran S.

Biophys J. 2015 May 19;108(10):2481-2491. doi: 10.1016/j.bpj.2015.03.059.

7.

The catalytic activity of the kinase ZAP-70 mediates basal signaling and negative feedback of the T cell receptor pathway.

Goodfellow HS, Frushicheva MP, Ji Q, Cheng DA, Kadlecek TA, Cantor AJ, Kuriyan J, Chakraborty AK, Salomon A, Weiss A.

Sci Signal. 2015 May 19;8(377):ra49. doi: 10.1126/scisignal.2005596.

8.

T-cell activation and early gene response in dogs.

Mortlock SA, Wei J, Williamson P.

PLoS One. 2015 Mar 24;10(3):e0121169. doi: 10.1371/journal.pone.0121169. eCollection 2015.

9.

Identification of thyroid carcinoma related genes with mRMR and shortest path approaches.

Xu Y, Deng Y, Ji Z, Liu H, Liu Y, Peng H, Wu J, Fan J.

PLoS One. 2014 Apr 9;9(4):e94022. doi: 10.1371/journal.pone.0094022. eCollection 2014.

10.

IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo.

Starbeck-Miller GR, Xue HH, Harty JT.

J Exp Med. 2014 Jan 13;211(1):105-20. doi: 10.1084/jem.20130901. Epub 2013 Dec 23.

11.

Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation.

Vassalli G.

J Transplant. 2013;2013:761429. doi: 10.1155/2013/761429. Epub 2013 Oct 24. Review.

12.

The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules.

Belicha-Villanueva A, Riddell J, Bangia N, Gollnick SO.

Lasers Surg Med. 2012 Jan;44(1):60-8. doi: 10.1002/lsm.21160. Epub 2012 Jan 3.

13.

Cestode antigens induce a tolerogenic-like phenotype and inhibit LPS inflammatory responses in human dendritic cells.

Terrazas CA, Sánchez-Muñoz F, Mejía-Domínguez AM, Amezcua-Guerra LM, Terrazas LI, Bojalil R, Gómez-García L.

Int J Biol Sci. 2011;7(9):1391-400. Epub 2011 Nov 1.

14.

The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Sigalov AB.

Self Nonself. 2010 Jul;1(3):192-224. Epub 2010 Jun 11.

15.

How tolerogenic dendritic cells induce regulatory T cells.

Maldonado RA, von Andrian UH.

Adv Immunol. 2010;108:111-65. doi: 10.1016/B978-0-12-380995-7.00004-5. Review.

16.

New therapeutic strategies targeting transmembrane signal transduction in the immune system.

Sigalov AB.

Cell Adh Migr. 2010 Apr-Jun;4(2):255-67. Epub 2010 Apr 24. Review.

17.

The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells.

Zhou D, Medoff BD, Chen L, Li L, Zhang XF, Praskova M, Liu M, Landry A, Blumberg RS, Boussiotis VA, Xavier R, Avruch J.

Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20321-6. doi: 10.1073/pnas.0810773105. Epub 2008 Dec 10.

18.

Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity.

Gay DL, Ramón H, Oliver PM.

Immunol Res. 2008;42(1-3):51-64. doi: 10.1007/s12026-008-8034-0. Review.

19.

Breast tumor microenvironment: proteomics highlights the treatments targeting secretome.

Chen ST, Pan TL, Juan HF, Chen TY, Lin YS, Huang CM.

J Proteome Res. 2008 Apr;7(4):1379-87. doi: 10.1021/pr700745n. Epub 2008 Feb 22. Review.

Supplemental Content

Support Center